The NHL released a statement Thursday regarding defenceman Jarred Tinordi‘s 20-game suspension.
Tinordi, a member of the Arizona Coyotes, received the suspension for violating the terms of the NHL/NHLPA Performance Enhancing Substances Program.
“We have received numerous media inquiries regarding the role and responsibility of the Montreal Canadiens’ franchise in relation to yesterday’s announcement of Jarred Tinordi’s suspension pursuant to the terms of the NHL/NHLPA Performance Enhancing Substances Program,” NHL deputy commissioner Bill Daly said in a statement.
“While we are not permitted under the terms of the CBA to provide any further detail or timeline with respect to the facts underlying Mr. Tinordi’s suspension, we would like to state that we have no reason to believe or conclude that the Canadiens acted inappropriately at any time in relation to this matter.
“NHL Clubs are not parties with whom information relating to the drug testing results or process are shared until a final determination has been made and formally announced by the League and NHLPA, which in this case was yesterday. The NHL has been given no basis whatsoever to consider reversing or revisiting the terms of the Montreal/Arizona transaction.”